Study of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic Phase
NCT05926128
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
75
Enrollment
OTHER
Sponsor class
Conditions
CML
Interventions
DRUG:
Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
Sponsor
Fundaleu